Dow Up0.00% Nasdaq Up0.09%

Enanta Pharmaceuticals, Inc. (ENTA)

46.94 Down 1.05(2.19%) Nov 28, 1:00PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.0
Mean Recommendation (last week):2.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:45.00
Median Target:45.00
High Target:50.00
Low Target:41.00
No. of Brokers:5

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Aug 15, 2014FBR CapitalInitiated Outperform
Jun 24, 2014Robert W. BairdDowngradeOutperformNeutral
Jan 28, 2014Robert W. BairdInitiated Outperform
Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy2221

Data provided by Thomson/First Call

Currency in USD.